Cheese Ingredients Market

Rising prevalence of chronic digestive disorders are propelling the growth for the Global Specialty Enzymes Market, says Fortune Business Insights in a report,  titled “Specialty Enzymes Market Size, Share and Global Trend By Product Type (Proteases, Lipases, Nucleases, Polymerases), By Source (Plants, Animals, Microbes), By Application (Diagnostics, Biotechnology R&D, Food, Cosmetics, Others), By End-User (Pharmaceutical Industries, Biotechnological Companies, Diagnostic Clinics, Education & Research Institutes, Others), and Geography Forecast till 2026.” Increasing R&D activities for the development of new digestive enzymes are predicted to foster the growth of the global specialty enzymes market.

Browse Complete Report:

Some of the major companies that are present in the global Specialty Enzymes market are

  • Specialty Enzymes & Probiotics
  • Merck
  • Aumgene Biosciences
  • Amano Enzyme Inc
  • Dyadic International Inc
  • Biocatalysts Ltd
  • Advanced Enzyme Technologies Ltd
  • BBI Solutions
  • Codexis,Inc
  • AB Enzymes
  • ArcticZymes Announces Ligase Enzyme

ArticZymes, a subsidiary of Biotec Pharmacon, launched its first ligase enzyme. T4 DNA ligase will be used for the development of products and kits helping the (IVD) In Vitro Diagnostic. The launch of the enzyme is likely to fuel demand among customers due to the high quality and commercial grade of ISO13485. The launch of T4 DNA is intended to expand the range of novel enzyme products and beyond. This factor is expected to boost the growth of the global specialty enzymes market. The launch of insulin-degrading enzymes by key players is also fostering the growth of the global specialty enzymes market. for instance, Creative Enzymes launched the insulin-degrading enzyme also referred to as insulin protease or insulysin for the researchers working in the life sciences industry. The aforementioned factors are positively impacting the global specialty enzymes market.

Get Sample PDF:

Increasing Cases of Immunodeficiency to Contribute Growth

Specialty enzymes have a wide range of applications in biofuel, pharmaceuticals industry, food supplements, biotechnology and others. The specialty enzymes market to witness high demand due to increasing cases of chronic digestive disorders along with rising research & development activities for the advancement of new digestive enzymes. The escalating acquisitions among key players is a factor boosting the specialty enzymes market during the forecast period. For instance, BASF acquired 71% of the enzyme producing company Verenium, in an acquisition deal, resulting in the creation of one of the biggest enzymes companies, leading to greater availability of specialty enzymes. Increasing incidences of digestive disorders such as inflammations, indigestion and also immunodeficiency are also contributing majorly to the market. Moreover, new technological advancements in the specialty enzymes are also predicted to foster growth to the global specialty enzymes market in the forthcoming year. Nonetheless, the high maintenance cost of specialty enzymes products along with rising safety regulations due to contamination are some of the factors restricting the growth of the global specialty enzymes market.

North America to Dominate the Global Market

Geographically, the global specialty enzymes market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are expected to lead the global specialty enzymes market during the forecast period. The presence of biopharmaceuticals companies in the region along with rising investment and acquisitions by leading companies in research and development for the introduction of potent specialty enzymes are some of the factors boosting the specialty enzymes market in the region. Asia-Pacific is projected to grow at a high CAGR during the forecast period. The increasing demand for specialty enzymes in diagnosing diseases such as cancer, cardiovascular disease and others, along with rising healthcare expenditure are factors driving the specialty enzymes market in the region.

Speak to Analyst:

About Us:           

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

View More Reports at:

Lung Cancer Therapeutics Market Worth US$ 48,725.9 Mn by Top International Players as Genentech, Celgene Corporation & more Forecast till 2026

Lung Cancer Therapeutics Market Analysis by Key Players, Geography and Major Segments Forecast 2018-2026

Rheumatoid Arthritis Therapeutics Market 2019 Global Industry Size, Outlook, Share, Demand, Manufacturers and 2025 Forecast